Chris Lau
4
All posts from Chris Lau
Chris Lau in Value Stocks,

Valeant Pharma Getting Papa Good News If it Happens

Joseph Papa is the CEO of PRGO. During his tenure, the stock increased eight-fold.

He is tough. He fought off Mylan's hostile takeover bid. 

His experience is suitable as leader. He has industry experience.

Caveat: PRGO is down 36% YTD, due to weak earnings and lower guidance. This is not unique. The entire sector is facing headwinds this year.

If Valeant negotiates Papa out of the non-compete clause, it's good news for the stock.